FDA Approves Lybalvi (olanzapine and samidorphan) for the Treatment of Schizophrenia and Bipolar I Disorder DUBLIN, June 1, 2021 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has approved Lybalvi (olanzapine and samidorphan) for the treatment of adults with schizophrenia and for the treatment of adults with… Read More »
Slightly more women are affected than men, and the condition is more common in people from the ages of 35 to 59. Past research has found that low levels of empathy correlated with low levels of social anxiety, and that social anxiety can increase along with empathy. Extremely low empathy was correlated with extremely low social… Read More »
Polycystic Ovarian Syndrome (PCOS) is the most common endocrine-related dysfunction in women of reproductive age. Multiple studies have observed a higher prevalence of psychiatric illness, including depressive disorders, anxiety disorders, and bipolar disorder in women with PCOS The nature of this association is not fully understood. Some have hypothesized that the hormonal dysregulation seen in… Read More »
However, this may not be effective for severe or long-term anxiety disorders. Symptoms of Generalized Anxiety Disorder The essential feature of generalized anxiety disorder is excessive anxiety and worry about a number of events or activities. For a reason that is only partially known, the brain’s fight-or-flight mechanism becomes activated, even when no real threat… Read More »